Mucosal dendritic cells in allergy and immunotherapy

To cite this article: Novak N, Allam J‐P. Mucosal dendritic cells in allergy and immunotherapy. Allergy 2011; 66 (Suppl. 95): 22–24. The oral epithelium contains oral mucosal Langerhans cells (oLCs) that constitutively express the high‐affinity IgE‐receptor FcεRI, the lipopolysaccharide receptor CD1...

Full description

Saved in:
Bibliographic Details
Published in:Allergy (Copenhagen) Vol. 66; no. s95; pp. 22 - 24
Main Authors: Novak, N., Allam, J.‐P.
Format: Journal Article Conference Proceeding
Language:English
Published: Oxford, UK Blackwell Publishing Ltd 01-07-2011
Blackwell
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To cite this article: Novak N, Allam J‐P. Mucosal dendritic cells in allergy and immunotherapy. Allergy 2011; 66 (Suppl. 95): 22–24. The oral epithelium contains oral mucosal Langerhans cells (oLCs) that constitutively express the high‐affinity IgE‐receptor FcεRI, the lipopolysaccharide receptor CD14 and toll‐like receptor (TLR)4. The distribution of oLCs profoundly differs at distinct oral mucosal sites, with higher numbers of oLCs detectable in the vestibulum compared with the sublingual region. The oLC response to activation of TLR4 and FcεRI and to binding of allergen suggests that these cells are involved in the maintenance of tolerance towards bacterial components and allergens. Thus, oLCs are important targets for allergens and adjuvants during sublingual immunotherapy, and characterizing them is crucial for improving allergen‐specific immunotherapy.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:0105-4538
1398-9995
DOI:10.1111/j.1398-9995.2011.02626.x